论文信息 - Expand: a Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib in Patients with Myelofibrosis and Baseline Platelet Counts Between 50 × 109/L and 99 × 109/L - 字舞流文

Expand: a Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib in Patients with Myelofibrosis and Baseline Platelet Counts Between 50 × 109/L and 99 × 109/L

S. Verstovsek | G. Barosi | A. Vannucchi | M. McMullin | C. Harrison | H. Gisslinger | Carole B. Miller | H. Al-Ali | V. Stalbovskaya | J. Kiladjian | A. Sirulnik | E. Atienza